2440. Weight-Adjusted Piperacillin–Tazobactam (PIP/TAZ) Therapy in Obese Patients vs. Optimized Doses in Non-obese Patients: A Retrospective Cohort Study

BACKGROUND: Dose optimized PIP/TAZ utilizing prolonged infusion has been shown to improve clinical outcomes. Previous pharmacokinetic studies of these prolonged infusion PIP/TAZ doses that achieve adequate time above minimum inhibitory concentration (T>MIC) in non-obese patients do not achieve si...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Sarah, Knoderer, Chad, Cheatham, S Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253462/
http://dx.doi.org/10.1093/ofid/ofy210.2093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253462/
http://dx.doi.org/10.1093/ofid/ofy210.2093

Ejemplares similares